Strides Pharma Science Limited (BOM:532531)

Strides Pharma Science Revenue

In the fiscal year ending March 31, 2026, Strides Pharma Science had annual revenue of 48.59B INR with 6.43% growth. Strides Pharma Science had revenue of 13.23B in the quarter ending March 31, 2026, with 11.18% growth.

• Revenue: 48.59B
• Revenue Growth: +6.43%
• P/S Ratio: 1.98
• Revenue / Employee: 14.72M
• Employees: 3,301
• Market Cap: 96.28B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	48.59B	2.93B	6.43%
Mar 31, 2025	45.65B	6.75B	17.36%
Mar 31, 2024	38.90B	2.02B	5.47%
Mar 31, 2023	36.88B	6.18B	20.13%
Mar 31, 2022	30.70B	-2.46B	-7.41%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 4, 2026

Data Sources Report a data error